Clinical of Fibronectin in Patients with Acute Myocardial Infarction Significance

LI Qing-sheng,WU Jing-sheng,ZHAI Zhi-min,HAN Yong-sheng,LI Qing,XU Xiu-cai,NI He-yu
DOI: https://doi.org/10.3969/j.issn.1009-6213.2005.02.010
2005-01-01
Abstract:Objective To investigate the expression of fibronectin (Fn) in patients with acute myocar-dial infarction (AMI) and its clinical significance. Methods A total of 12 patients with AMI, and 13 healthy controls. The expression of Fn on peripheral blood platelet membrane were analyzed with flow cytometry. Soluble Fn in plasma was assayed by enzyme-linked immunoadsorbent assay (ELISA) . Results The expression of Fn on peripheral blood platelet membrance was 67. 88±19. 55% and the plasma Fn was 515. 17±83. 85 mg/ L in patients with AMI. While those in controls were 14. 35±5. 31% and 361. 54±68. 48 mg/L respectively, indicating a higher expression of Fn on peripheral blood platelet membrance and plasma Fn level in patients with AMI than in control group (P 0. 01). Conclusion It suggested that Fn might contribute to artery thrombosis in patients with AMI.
What problem does this paper attempt to address?